AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 239 filers reported holding AMICUS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $303,000 | -88.6% | 31,946 | -86.1% | 0.01% | -91.4% |
| Q4 2021 | $2,659,000 | +97.0% | 230,186 | +62.8% | 0.07% | +180.0% |
| Q3 2021 | $1,350,000 | +9.0% | 141,392 | +10.1% | 0.02% | +8.7% |
| Q2 2021 | $1,238,000 | +714.5% | 128,430 | +736.0% | 0.02% | +666.7% |
| Q1 2021 | $152,000 | -95.2% | 15,362 | -88.9% | 0.00% | -94.8% |
| Q4 2020 | $3,194,000 | +62.7% | 138,348 | -0.5% | 0.06% | -1.7% |
| Q3 2020 | $1,963,000 | +58.3% | 139,022 | +69.1% | 0.06% | 0.0% |
| Q2 2020 | $1,240,000 | – | 82,200 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |